Skip to main content

Precision medicine in the field of radiooncology enables women to maintain an active sex life after gynaecological radiotherapy

All News

(Vienna, 02 November 2017) Up until now, gynaecological radiotherapy for cervical, vaginal or vulvar cancer has often been associated with substantial side-effects in the vagina that prevented women from pursuing an active sex life afterwards. Using new medical methods and techniques that allow women to receive personalised and precisely tailored treatment, it is now increasingly possible for women to lead a fulfilling sex life even after undergoing radiotherapy. This point was made by Kathrin Kirchheiner, expert in sexual medicine from the Department of Radiotherapy, speaking on the occasion of the European Gynaecological Oncology Congress (ESGO), which is being held in the Austria Center Vienna from 4 – 7 November, under the aegis of MedUni Vienna.

"For a long time sexuality was a taboo subject among cancer patients," says Kirchheiner, "but new research findings and modern radiotherapy techniques now enable women to contemplate having a fulfilling sex life, even after treatment."

This is due to the combination of three mainstays of precision medicine in radiooncology: optimum prevention, precise irradiation of the tumour and subsequent sexual counselling. Preventive measures include even more careful planning of radiotherapy to direct a high dose of radiation at the tumour while sparing healthy tissue and surrounding organs, including part of the vagina, as far as possible. With the very latest radiotherapy methods of external and internal irradiation, it is now possible to adapt the treatment very accurately to the individual patient, thereby significantly minimising potential side-effects. Subsequent sexual counselling can help patients to cope better with any physical or even psychological changes they have undergone as a result of the cancer diagnosis and treatment.   

Optimised collaboration
Precise and individualised treatment of affected patients is made possible by optimised collaboration between several different departments and divisions within MedUni Vienna/Vienna General Hospital. Alongside the Department of Radiotherapy, these include the Department of Obstetrics and Gynecology – in particular the Division of General Gynecology and Gynecologic Oncology headed up by Heinz Kölbl – as well as the tumour board of the Comprehensive Cancer Center Vienna (CCC) and the "Sexual Health in Cancer Patients" platform.

Every year a total of around 150 women undergo gynaecological radiotherapy at Vienna General Hospital and/or MedUni Vienna and their after-care is centred around helping them to maintain a fulfilling sex life with support from the three mainstays: prevention, precise radiotherapy and psychological support.

ESGO 2017
The ESGO (European Gynaecological Oncology Congress 2017) will take place in the Austria Center Vienna from 4 – 7 November. Heinz Kölbl, Head of the Division of General Gynecology and Gynecologic Oncology at MedUni Vienna's Department of Gynaecology will preside as Congress Chairman. For more information: https://congress.esgo.org/. The "Sexual Medicine Co-Session" will be led by Kathrin Kirchheiner, with talks by renowned experts Michal Zikan and Moniek ter Kuile.